Exploratory Study to Evaluate the Effect of SYN111 (Rufinamide) in Patients With Generalized Anxiety Disorder (GAD)

Clinical trial NCT00595231 · COMPLETED

Trial details

NCT number: NCT00595231
Sponsor: Biotie Therapies Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Generalized Anxiety Disorder

Start date: 2008-03-01
Primary completion: 2008-10-01
Enrollment: 239

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.